282 related articles for article (PubMed ID: 21103967)
1. Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms.
König J
Handb Exp Pharmacol; 2011; (201):1-28. PubMed ID: 21103967
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of human OATP transporters.
König J; Seithel A; Gradhand U; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):432-43. PubMed ID: 16525793
[TBL] [Abstract][Full Text] [Related]
3. The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members.
Seithel A; Glaeser H; Fromm MF; König J
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):51-64. PubMed ID: 18370858
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
5. The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance.
Fenner KS; Jones HM; Ullah M; Kempshall S; Dickins M; Lai Y; Morgan P; Barton HA
Xenobiotica; 2012 Jan; 42(1):28-45. PubMed ID: 22077101
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.
Zaïr ZM; Eloranta JJ; Stieger B; Kullak-Ublick GA
Pharmacogenomics; 2008 May; 9(5):597-624. PubMed ID: 18466105
[TBL] [Abstract][Full Text] [Related]
7. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties.
Hagenbuch B; Meier PJ
Pflugers Arch; 2004 Feb; 447(5):653-65. PubMed ID: 14579113
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.
Burckhardt G; Burckhardt BC
Handb Exp Pharmacol; 2011; (201):29-104. PubMed ID: 21103968
[TBL] [Abstract][Full Text] [Related]
9. Role of OATP transporters in the disposition of drugs.
Niemi M
Pharmacogenomics; 2007 Jul; 8(7):787-802. PubMed ID: 18240907
[TBL] [Abstract][Full Text] [Related]
10. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of the OATP and OAT families.
Marzolini C; Tirona RG; Kim RB
Pharmacogenomics; 2004 Apr; 5(3):273-82. PubMed ID: 15102542
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatic organic anion-transporting polypeptide by RNA interference in sandwich-cultured human hepatocytes: an in vitro model to assess transporter-mediated drug-drug interactions.
Liao M; Raczynski AR; Chen M; Chuang BC; Zhu Q; Shipman R; Morrison J; Lee D; Lee FW; Balani SK; Xia CQ
Drug Metab Dispos; 2010 Sep; 38(9):1612-22. PubMed ID: 20516252
[TBL] [Abstract][Full Text] [Related]
13. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin.
Briz O; Serrano MA; MacIas RI; Gonzalez-Gallego J; Marin JJ
Biochem J; 2003 May; 371(Pt 3):897-905. PubMed ID: 12568656
[TBL] [Abstract][Full Text] [Related]
14. Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects.
Fahrmayr C; Fromm MF; König J
Drug Metab Rev; 2010 Aug; 42(3):380-401. PubMed ID: 20100011
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.
Tamai I; Nezu J; Uchino H; Sai Y; Oku A; Shimane M; Tsuji A
Biochem Biophys Res Commun; 2000 Jun; 273(1):251-60. PubMed ID: 10873595
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1).
van de Steeg E; van der Kruijssen CM; Wagenaar E; Burggraaff JE; Mesman E; Kenworthy KE; Schinkel AH
Drug Metab Dispos; 2009 Feb; 37(2):277-81. PubMed ID: 19022939
[TBL] [Abstract][Full Text] [Related]
17. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
18. Organic anion transporters and their implications in pharmacotherapy.
Emami Riedmaier A; Nies AT; Schaeffeler E; Schwab M
Pharmacol Rev; 2012 Jul; 64(3):421-49. PubMed ID: 22457399
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics.
Neuvonen PJ
Curr Opin Investig Drugs; 2010 Mar; 11(3):323-32. PubMed ID: 20178046
[TBL] [Abstract][Full Text] [Related]
20. Oral drug delivery utilizing intestinal OATP transporters.
Tamai I
Adv Drug Deliv Rev; 2012 May; 64(6):508-14. PubMed ID: 21824501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
